The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|20|2525-2533

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.20, 2004-08, pp. : 2525-2533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac-Specific Expression of the Hepatocyte Growth Factor (HGF) Under the Control of a TnIc Promoter Confers a Heart Protective Effect After Myocardial Infarction (MI)

By  

Current Gene Therapy, Vol. 14, Iss. 1, 2014-02 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Regenerative Approaches to Post-Myocardial Infarction Heart Failure

By  

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1930-1940

Bentham Science Publishers

Access to resources Recommend Favorite

The Myocardial Na/H Exchanger: A Potential Therapeutic Target for the Prevention of Myocardial Ischaemic and Reperfusion Injury and Attenuation of Postinfarction Heart Failure

By Karmazyn M.   Sostaric J.V.   Gan X.T.  

Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. : 375-389

Adis International

Access to resources Recommend Favorite

The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure

By Egom Emmanuel EA   Mamas Mamas A   Clark Andrew L  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 791-800

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Monteplase in Acute Myocardial Infarction

By Inoue Teruo  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 4, 2005-01 ,pp. : 225-231

Adis International

Access to resources Recommend Favorite